Anfibatide Treatment in STEMI Patients
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 240 participants.
Also called NCT02495012
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 240 participants
- Sponsor
- Registry
-
NCT02495012
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02495012. Randomized; double masking; primary purpose treatment. Start 2015-08 (registry gives no type); primary completion 2016-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Anfibatide Treatment in STEMI Patients
- Condition
- ST Segment Elevation Myocardial Infarction
- Intervention (Drug)
- placebo
- Intervention (Drug)
- Anfibatide
- Lead sponsor
- Lee's Pharmaceutical Limited
Record details
- Record id
cardio:ct-nct02495012- Content hash
0a085365d211a056572d3b6b6193fab9063f1cb8a86ceda1421194cf198c2e26